1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary safety and efficacy of IPI-145, a potent inhibitor of phosphoinositide-3-kinase-δ,γ, in patients with relapsed/refractory CLL
    Meeting Abstract

    Patel, M. R.; Kahl, B. S.; Horwitz, S. M.; Younes, A.; Foss, F. M.; Oki, Y.; Sweeney, J.; Allen, K.; Faia, K.; Kelly, P. F.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Predictors of adequate financial resources 5 years after breast cancer diagnosis in low-income women
    Meeting Abstract

    Patil, S.; Blinder, V. S.; Gany, F.; Maly, R. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of ridaforolimus (MK-8669) in pediatric patients with advanced solid tumors
    Meeting Abstract

    Pearson, A. D. J.; Federico, S. M.; Aerts, I.; Hargrave, D. R.; DuBois, S. G.; Iannone, R.; Geschwindt, R.; Wang, R. X.; Trippett, T. M.; Geoerger, B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Continuation of sunitinib following RECIST progression on first-line sunitinib
    Meeting Abstract

    Burotto Pichun, M. E.; Wilkerson, J.; Stein, W. D.; Motzer, R. J.; Bates, S. E.; Fojo, T.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Effect of margin width on local recurrence (LR) in triple-negative (TN) breast cancer treated with breast-conserving therapy (BCT)
    Meeting Abstract

    Pilewskie, M. L.; Ho, A. Y.; Orell, E.; Stempel, M.; Chen, Y.; Eaton, A.; Patil, S.; Morrow, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Does biomarker information impact patients' preferences for therapy?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A.; Miller, K.; Baker, E.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.; Schneider, B. P.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Patterns of metastasis and survival in patients with PI3K pathway-driven stage IV squamous cell lung cancers (SQCLC)
    Meeting Abstract

    Paik, P. K.; Moreira, A. L.; Wang, L.; Won, H. H.; Hasanovic, A.; Rekhtman, N.; Sima, C. S.; Ladanyi, M.; Berger, M. F.; Kris, M. G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Impact of neoadjuvant chemotherapy plus HER2-targeting on breast conservation rates: Surgical results from CALGB 40601 (Alliance)
    Meeting Abstract

    Ollila, D. W.; Berry, D. A.; Cirrincione, C.; Carey, L. A.; Amos, K. D.; Henry, N. L.; Winer, E. P.; Hudis, C.; Golshan, M.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Polyvalent vaccine-KLH conjugate and OPT-821 with bevacizumab (BEV) in patients with ovarian cancer in second or greater remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Iasonos, A.; Zhou, Q.; Durany, R.; Aghajanian, C.; Hensley, M. L.; Konner, J. A.; Makker, V.; Tew, W. P.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial
    Meeting Abstract

    O'Connor, O. A.; Masszi, T.; Savage, K. J.; Pinter-Brown, L. C.; Foss, F. M.; Popplewell, L.; Cashen, A. F.; Doorduijn, J.; Chawla, S.; Knoblauch, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save